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Summary: The sensing of foreign agents by the innate and adaptive
immune system triggers complex signal transduction cascades that cul-
minate in expression of gene patterns that facilitate host protection
from the invading agent. Post-translational modification of intracellular
signaling proteins in these pathways is a key regulatory mechanism
with ubiquitination being one of the important processes that controls
levels and activities of signaling molecules. E3 ubiquitin ligases are the
determining enzymes in dictating the ubiquitination status of individ-
ual proteins. Among these hundred E3 ubiquitin ligases are a family of
Pellino proteins that are emerging to be important players in immunity
and beyond. Herein, we review the roles of the Pellino E3 ubiquitin
ligases in innate and adaptive immunity. We discuss their early discov-
ery and characterization and how this has been aided by the highly
conserved nature of innate immune signaling across evolution. We
describe the molecular roles of Pellino proteins in immune signaling
with particular emphasis on their involvement in pathogen recognition
receptor (PRR) signaling. The growing appreciation of the importance
of Pellino proteins in a wide range of immune-mediated diseases are
also evaluated.
Keywords: Pellino E3 ubiquitin ligases, innate immunity, Toll-like receptors, NOD-
like receptors, inflammation, ubiquitination
Conserved innate immune signaling as the gateway to
discovering Pellino
The primary sensing of invading pathogens by the host
immune system is facilitated by pattern recognition receptors
(PRRs) that recognize pathogen-associated molecular patterns
(PAMPs). Such PRRs include families of receptors like Toll-
like receptors (TLRs) (1) and NOD-like receptors (NLRs) (2)
that trigger signal transduction pathways to regulate gene
expression patterns that are adapted toward protecting the
host from the pathogen. Taking TLRs as the founding mem-
bers of the PRR family and the paradigm for PRR signaling,
these receptors promote activation of nuclear factor-jB (NF-
jB) and interferon (IFN) regulatory factors (IRFs) to induce
proinflammatory cytokines, like interleukin-1 (IL-1) and
tumor necrosis factor (TNF), and anti-viral interferons (IFNs)
(3) (Fig. 1). TLRs are transmembrane proteins with many
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members of the family, like TLR4, being located in the plasma
membrane where they can recognize PAMPs such as lipopoly-
saccharide (LPS) on the microbial surface (4). Other TLRs,
like TLR3, are located in endosomal membranes where they
can detect nucleic acid from viruses that have infected the cell.
All TLRs share with the IL-1 receptor (IL-1R) an intracellular
Toll/IL-1R (TIR) homology domain and stimulation of TLRs
by respective PAMPs facilitates the recruitment of specific TIR
adapter proteins to the TIR domain of the activated TLR (1).
All TLRs, with the exception of TLR3, recruit the TIR adapter
myeloid differentiation primary response protein 88
(MyD88) (5). Most of these TLRs and IL-1R interact directly
with MyD88, via homotypic TIR associations, but TLR4
requires the bridging adapter MyD88 adapter like (Mal) to
recruit MyD88. The association of MyD88 with TLRs facili-
tates recruitment of members of the IL-1R-associated kinase
(IRAK) family, such as IRAK-1 and IRAK-4, leading to their
hyper-phosphorylation and interaction with the E3 ubiquitin
ligase TRAF6 (6–9). The formation of K63 polyubiquitin
chains by TRAF6 serves to bring TAK1 kinase into close prox-
imity with its substrates IjB kinases (IKKs) (10, 11). Activa-
tion of the latter leads to phosphorylation and subsequent
proteasomal degradation of the NF-jB inhibitory proteins
IjB, allowing for nuclear translocation of NF-jB and its
induction of a plethora of pro-inflammatory genes (12, 13).
Most TLRs use this MyD88-dependent pathway to activate
NF-jB, but TLR4 can additionally deploy another adapter pro-
tein, TIR domain-containing adapter protein inducing IFN-b
(TRIF), via bridging TRIF-related adapter molecule (TRAM),
to trigger a MyD88-independent pathway that also activates
NF-jB (14). TLR3 interacts directly with TRIF that then acti-
vates RIP1 kinase to trigger downstream IKK-mediated activa-
tion of NF-jB (15, 16). TRIF can also deploy the IKK-related
kinases IKKe (also known as IKKi) and TANK-binding kinase
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Fig. 1. Pellino1 and Pellino3 regulate Toll-like receptor (TLR) signaling. Lipopolysaccharide (LPS) stimulates TLR4 to interact with MyD88,
via the bridging adapter Mal. This results in recruitment and phosphorylation of IRAKs that stimulate TRAF6 to sequentially activate TAK1 and the
IKK complexes resulting in downstream activation of NF-jB and induction of the pro-inflammatory genes encoding TNF and interleukin-6 (IL-6).
TLR4, via TRAM, and TLR3 recruit TRIF that then interacts with RIP1. Pellino1 catalyses K63-linked polyubiquitination of RIP1 that facilitates the
recruitment of the TAK1 and IKK complexes via the ubiquitin-binding domains of the associated TGFb-activated kinase 1 binding proteins (TABs)
and NF-jB essential modulator (NEMO) respectively. This culminates in TAK1-mediated activation of NF-jB. TRIF also activates IKKe/TBK1 to
phosphorylate and activate IRF3 and IRF7 resulting in induction of type I IFNs. IRF3 also induces Pellino1 that is subject to phosphorylation and
activation by IKKe/TBK1. Pellino1 interacts with the deformed epidermal autoregulatory factor-1 (DEAF1) transcription factor and both of these
proteins augments binding of IRF3 to the IFNb promoter. TRIF can also trigger TRAF6-mediated K63-linked polyubiquitination of IRF7 that
promotes its nuclear translocation and induction of Pellino3. The latter catalyzes K63-linked polyubiquitination of TRAF6 that inhibits the TRAF6/
IRF7 interaction, impairs ubiquitination of IRF7 culminating in reduced nuclear translocation of IRF7 and repression of type I IFN expression.
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1 (TBK1) to catalyze phosphorylation and activation of IRF3
and IRF7 leading to their nuclear translocation and induction
of type I IFNs (3, 17).
These PRR signaling pathways are highly conserved across
evolution with early studies on innate immunity in primi-
tive organisms like Drosophila informing discovery on the
components and organization of PRR pathways in mamma-
lian systems (18). In an analogous manner to MyD88-
dependent signaling by mammalian TLRs, Drosophila Toll uti-
lizes adapter molecules, like dMyD88 and tube, to connect
to the IRAK homologue Pelle (19, 20) and Pelle then trig-
gers downstream activation of NF-jB family members Dor-
sal and Dif to induce the expression of antibacterial genes
(21–23). Using Pelle as a bait in a yeast two hybrid screen,
Pellino was first identified in Drosophila as a Pelle-interacting
protein (24). A later report demonstrated that Pellino is
required for induction of the antimicrobial peptide droso-
mycin and as a positive regulator of innate immunity in
response to Gram-positive bacterial infection (25). Interest-
ingly a more recent study has reported a directly contrasting
role for Drosophila Pellino as a negative regulator of Toll sig-
naling and inhibitor of antibacterial responses to Gram-posi-
tive bacteria (26). The authors demonstrate that upon
stimulating Toll, Pellino is recruited to the plasma mem-
brane-bound Drosophila MyD88 resulting in ubiquitination
and degradation of Drosophila MyD88 (dMyD88) and sup-
pression of downstream Toll signaling and repression of
anti-bacterial peptides. It is presently unclear as to why these
2 studies demonstrate such directly opposing roles for Pelli-
no in Drosophila Toll signaling.
The initial discovery of Pellino in Drosophila laid the foun-
dation for the subsequent identification of three members of
the mammalian Pellino family (Pellino1, 2, and 3) with Pel-
lino3 being expressed in two alternative spliced forms (27–
31). The Pellino-Pelle interaction is conserved in evolution
as indicated by Pellino1 (28), Pellino2 (27, 32, 33), and
Pellino3 (29) being capable of interacting with the Pelle or-
thologues IRAK-1 and IRAK-4. There is some confusion in
relation to the requirement of IRAK kinase activity for medi-
ating such interactions with some studies indicating a
requirement (29, 34, 35) while we and others suggest that
kinase activity is dispensable (32, 36, 37). The first studies
also demonstrated that Pellino proteins can interact with
other downstream TLR signaling molecules including TRAF-
6 and TAK-1 initially suggesting that the primary Pellino
function is to provide a scaffold framework for signaling
complex assembly in TLR/IL-1R signaling (28, 29, 33, 38).
Pellino proteins contain RING-like and FHA domains
Early bioinformatic studies indicated that Pellino proteins
contained a putative RING-like domain in their C-termini
(30). A RING domain consists of a conserved pattern of cys-
teine and histidine residues that forms a structure that is
capable of coordinating two zinc atoms and is a defining
feature of the RING class of E3 ubiquitin ligases (39). Pelli-
no proteins contain a conserved pattern of cysteine and his-
tidine residues that resembles the canonical RING motif
suggesting that they may be E3 ubiquitin ligases. This was
supported when co-expression of Pellino proteins and IRAK-
1 resulted in ubiquitination of the latter whereas Pellino
forms with mutations in their RING-like domain were inef-
fective (34). We provided the first direct evidence to con-
firm that all three mammalian Pellino proteins have intrinsic
E3 ligase catalytic activity in vitro (36). While co-expression
of Pellino proteins and IRAK-1 in cells results in the ubiqui-
tination of IRAK-1 by K63-linked polyubiquitin chains, in
an in vitro setting Pellino1 can work with the E2 enzyme
Ubc13-Uev1a to form K63-linked polyubiquitin chains,
whereas in conjunction with UbcH4 or UbcH5a/UbcH5b
E2 enzymes, the polyubiquitin chains have mainly K11 and
K48 linkages (37). Furthermore, the K63-linked chains gen-
erated by Pellino1 in vitro are unanchored whereas the K11/
K48 chains are anchored to IRAK or the Pellino protein
itself. Whereas Pellino1 catalyzes the formation of unan-
chored K63-linked chains in vitro, the co-expression of Pelli-
no1 and IRAK1 in cells leads to the formation of K63-linked
chains that are attached to IRAK-1 (37). This difference may
be due to Pellino proteins initially employing an E2 enzyme
other than Ubc13-Uev1a to ligate the first ubiquitin to
IRAK-1 in cells and this ubiquitin then seeds a growing
K63-linked chain that is catalyzed by Pellino proteins in
association with Ubc13-Uev1a. Alternatively, a different E3
ligase may add the first ubiquitin moiety.
While the RING-like domain is essential for mediating
Pellino-induced ubiquitination of IRAK-1, it is dispensable
for the Pellino-IRAK interactions (34, 35). Indeed truncation
mutants of the Pellino proteins that lack the entire C-termi-
nus RING-like domain are capable of binding to IRAK-1
(35). The x-ray crystal structure of this corresponding N-
terminal fragment of Pellino2, that lacks its RING-like
domain, has been resolved and uncovers a cryptic Forkhead-
associated (FHA) domain that was not apparent from pri-
mary sequence analysis (35). The FHA domain is a recog-
nized phosphothreonine-binding module (40, 41). The
canonical FHA domain contains a number of highly
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
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conserved residues that directly contact the phosphothreo-
nine residue of the target protein and mutation of these cor-
responding residues in Pellino2 abrogates its ability to bind
IRAK-1, suggesting that Pellino2 recognizes IRAK-1 via a
functional FHA domain. Furthermore, the Pellino2 FHA
domain can bind to phosphothreonine-containing peptides
and enzymatic dephosphorylation of IRAK-1 precludes its
binding to the Pellino2 FHA domain. While the target phos-
phothreonine residue(s) on IRAK-1 has yet to be identified
the above findings strongly indicate that Pellino2 uses its
FHA domain to recognize phosphorylated IRAK-1. In addi-
tion to Pellino2 containing a core FHA domain, the x-ray
crystal structure also revealed that Pellino2 contains a ‘wing’
or appendage that is unique among FHA structures. The
wing is tightly packed against the FHA core structure and
may work with the FHA domain in recognizing target pro-
teins. Based on amino acid similarity, apart from some loop
regions, the core FHA domain and wing structures are con-
served across the Pellino family (35) and the FHA-mediated
recognition of phosphorylated target proteins is likely to be
a common feature of all members of the family. However,
as described below, members of the mammalian Pellino
family do not appear to show functional redundancy with
different Pellino proteins demonstrating preference for par-
ticular substrate proteins. A recent study has shown that
whilst the FHA domain in Pellino proteins mediates interac-
tions with target proteins via recognition of phospho-threo-
nine residues, the affinity of the FHA domain for the target
protein is also dependent on the local amino acid sequence
context of the phosphothreonine residue, with the FHA
domains from the different Pellino proteins displaying vary-
ing affinities for different surrounding sequences. This likely
underlies the strong recognition of RIP1 but not TRAF6 by
Pellino1 whereas Pellino3 demonstrates high affinity for
TRAF6 (42).
Pellino proteins are modified by ubiquitination and
sumoylation
While IRAKs are subject to ubiquitination by Pellino pro-
teins the latter are substrates for the kinase activity of IRAKs.
Both IRAK-1 and IRAK4 catalyze in vitro phosphorylation of
Pellino proteins (32, 34, 37) resulting in increased E3 ligase
activity (37) and auto-ubiquitination of Pellino1 on residues
K169, K202, and K266 (43). In a cell setting, the conse-
quence of IRAK-1-induced activation and ubiquitination of
Pellino proteins may be Pellino degradation given that over-
expression of a kinase-active form of IRAK results in
polyubiquitination and decreased expression levels of Pellino
proteins (36). Conversely, cells that lack IRAK-1 or express-
ing kinase-dead IRAK-1 demonstrate augmented expression
levels of Pellino1 (44). If auto-ubiquitination of Pellino pro-
teins leads to degradation the underlying mechanism
remains to be defined. In a cell setting, Pellino proteins tend
to catalyze ubiquitination of substrate proteins by K63-
linked polyubiquitin chains whereas K48-linked chains nor-
mally provide the signature for proteasome-mediated degra-
dation. However, a recent report has shown that
ubiquitination of Pellino3 results in its lysosomal degrada-
tion by selective autophagy whereas blockade of the protea-
some had no effect on Pellino3 degradation (45).
In addition to being subject to post-translational modifica-
tion by ubiquitination, Pellino1 can also be modified by
covalent attachment of the small ubiquitin-like modifier
(SUMO) protein at residues K202, K266, K295, K299, and
K303 (46). Such sumoylation is catalyzed by the SUMO-
conjugating enzyme Ubc9 and it is interesting to note that
some of the sumoylation sites in Pellino1 are common to
the ubiquitination sites above suggesting competition
between sumoylation and ubiquitination. The functional
consequence of Ubc9-induced sumoylation of Pellino1 is
currently unknown.
Phosphorylation of Pellino proteins
The IRAK-1 and IRAK-4 phosphorylation sites in Pellino1
have been identified and correspond to multiple serine
(S)/threonine (T) residues with S76, S78, T80, S82, and
T86 being located in the wing appendage outside the core
FHA domain and T288 and S293 just prior to start of the
RING-like domain (43). Interestingly, the phosphorylation
of any one of the residues S76, T288, and S293, or by
the combined phosphorylation of the residues S78, T80,
and S82 is sufficient to reveal full Pellino1 E3 ligase activ-
ity. This has important consequences for any phosphatase-
based mechanisms that may inactivate Pellino function
since dephosphorylation of multiple sites would be
required to terminate activity. Given such a challenge, it
may not be surprising that Pellino degradation may be an
important mechanism for negatively regulating Pellino
function. Most of the IRAK phosphorylation sites in Pelli-
no1 are conserved in Pellino2 and Pellino3, suggesting
that the phosphorylation and activation of each member
of the Pellino family by IRAKs is likely mediated by a
common mechanism. However, some of these sites are
also conserved in Drosophila Pellino and mutation of these
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
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serine/threonine residues to alanine fail to affect the E3
ligase activity of Drosophila Pellino or its regulatory effects
on Toll signaling (26).
More recently IKKe and TBK1 kinases, which mediate
TRIF-dependent activation of IRF3, have also been shown
to be capable of phosphorylating and activating Pellino1
(47). In this study, a yeast-two hybrid screen initially
identified IKKe as an interacting protein with the FHA
domain of Pellino1 and both IKKe and TBK1were subse-
quently shown to phosphorylate and activate the E3 ligase
activity of Pellino1 in vitro. The major TBK1 phosphoryla-
tion sites on Pellino1 were also identified as S76, T80,
T288, and S293. As discussed above, a number of these
residues are key activation sites and provide a likely
molecular basis to TBK-1/IKKe induced activation of Pelli-
no1. While stimuli, such as LPS and Poly(I:C) that trigger
the TRIF/TBK1/IKKe pathway, have been shown to stimu-
late the E3 ligase activity of Pellino1 in cells, it has not
been technically possible to detect the phosphorylation
sites on endogenous Pellino1 (47). Interestingly, in addi-
tion to activating Pellino1, the TRIF/TBK1/IKKe pathway
can also induce expression of Pellino1 via the transcription
factor IRF3, and this may explain the high levels of Pelli-
no1 in rhinovirus-infected bronchial epithelial from COPD
patients (48).
Since IRAK and TBK1/IKKe kinases are capable of phos-
phorylating Pellino1, a study explored the relative impor-
tance of these kinases in various pathways that can activate
Pellino1 (44). Unexpectedly, the role of IRAK-1 appears to
be restricted to mediating IL-1-induced activation of Pelli-
no1, whereas TNF signaling and TLRs use TBK1/IKKe kinas-
es to stimulate Pellino1. Given that a number of these TLRs
can also strongly activate IRAK-1, the mechanism by which
a given pathway selects a discrete kinase to phosphorylate
and activate Pellino1 awaits clarification.
Molecular studies have thus demonstrated Pellino proteins
to contain a FHA domain that enables their interaction with
kinases such as IRAK-1, IRAK-4 and TBK1/IKKe resulting in
Pellino phosphorylation, activation of their E3 ligase activity
and ubiquitination of substrate proteins including some of
their kinase partners such as IRAK-1. We now move to dis-
cuss the downstream functional and physiological conse-
quences of these molecular roles of the Pellino family. The
largely conserved nature of the FHA and RING-like domains
across the Pellino family would suggest that Pellino proteins
may share common functions but studies are revealing spe-
cialized physiological roles for individual members of the
Pellino family.
Physiological roles of Pellino proteins in PRR signaling
Pellino1 mediates TRIF-dependent TLR signaling
Pellino1-deficient mice have been very valuable in implicat-
ing specific roles for Pellino1 in TLR3 and TLR4 biology
(49). Pellino1-deficient mice are viable and develop nor-
mally but are less responsive than wildtype mice to the
TLR3 and TLR4 ligands, Poly(I:C), and LPS, respectively, in
terms of induction of pro-inflammatory genes like TNF and
IL-6. Consequently, Pellino1 deficiency results in resistance
to septic shock normally effected by Poly(I:C) and LPS. This
is also consistent with reduced TLR3/TLR4-induced activa-
tion of IKKs and NF-jB in cells from Pellino1-deficient mice
whereas the activation of these inflammatory pathways by
other TLRs are generally unaffected suggesting a specificity
for Pellino1 in mediating TLR3 and TLR4 signaling. Pellino1
was shown to mediate TRIF-dependent activation of NF-jB
by interacting with the downstream kinase RIP1 and catalyz-
ing its ubiquitination (49), thus triggering downstream acti-
vation of IKKs and NF-jB (15) (Fig. 1). This adds to our
understanding of the sequence of intracellular signaling
events in TLR3 and TLR4 pathways in that their stimulation
results in the RIP homotypic interaction motif in TRIF inter-
acting with RIP1 (16) followed by recruitment of Pellino1
(49). Since the latter is phosphorylated and activated by
TBK1/IKKe, that are also triggered by TRIF (44), this results
in Pellino1-mediated ubiquitination of RIP1 and the recruit-
ment of TAK-1 and IKK complexes to the polyubiquitin
chains (Fig. 1). TAK-1-mediated phosphorylation of IKKs
culminates in downstream activation of NF-jB and a path-
way by which Pellino1 can contribute to the expression of
pro-inflammatory genes. This is also supported by a recent
study demonstrating that mice expressing a Pellino1 trans-
gene show increased levels of pro-inflammatory cytokines
like TNF and IL-6 (50).
While TRIF utilizes RIP1 to activate the NF-jB pathway it
can also recruit TBK1/IKKe kinases to activate IRF transcrip-
tion factors and induce type I IFNs like IFNb (14, 17, 51–
53) (Fig. 1). However, fibroblasts from Pellino1-deficient
mice retain full capacity for TLR3 and TLR4-induced activa-
tion of IRFs and expression of IFNb suggesting that Pellino1
mediates TRIF-dependent activation of NF-jB and induction
of pro-inflammatory genes but does not regulate the TRIF-
IRF3-IFNb signaling axis (49). Such selectivity of Pellino1
for the NF-jB arm also applies to human bronchial epithe-
lial cells in which Pellino1 knockdown suppresses virus-
induced expression of IL-6 and CXCL8 but not IFN-related
genes (54). However, a knockin mouse expressing an E3
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
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ligase dead form of Pellino1 has questioned the selective
effect of Pellino1 on NF-jB (55). The inactive mutant form
of Pellino1 showed similar expression patterns as wildtype
Pellino although the expression levels of the mutant protein
were lower. Unlike Pellino1-deficient mice, macrophages
from the Pellino1-ligase dead knockin mice showed normal
Poly(I:C)-induced ubiquitination of RIP1, activation of NF-
jB and induction of pro-inflammatory genes (55). How-
ever, Poly(I:C)/LPS-induced expression of IFNb was greatly
reduced in macrophages and dendritic cells from knockin
mice and this was associated with reduced recruitment of
IRF3 to the IFNb promoter. This suggests that the E3 ligase
activity of Pellino 1 facilitates the recruitment of IRF3 to the
IFNb promoter with a recent report describing the transcrip-
tion factor deformed epidermal autoregulatory factor 1
(DEAF1) as a Pellino1-interacting protein that associates
with IRF3 and the IFNb promoter to drive IFNb expression
(56) (Fig. 1).
Pellino1-deficient mice and knockin mice in which wild-
type Pellino1 is replaced by a point mutant lacking E3
ubiquitin ligase activity offer contrasting conclusions on the
roles of Pellino1 in TRIF-mediated signaling. The former
indicates a critical role for Pellino1 in promoting ubiquitina-
tion of RIP1 and downstream inflammatory signaling,
whereas findings from the knockin mice propose that the
loss of E3 ligase activity in Pellino1 has no consequence for
RIP1 ubiquitination but instead is key for specifically activat-
ing the IFNb promoter. This may suggest that Pellino1 pro-
motes ubiquitination of RIP1 in an indirect manner that is
independent of its intrinsic E3 ligase activity.
Pellino3 negatively regulates TLR3 signaling
We have generated Pellino3-deficient mice and while they
develop normally, they have been very valuable in revealing
a novel regulatory role for Pellino3 in TLR3 biology (57).
Cells from these mice respond normally to a range of TLR
ligands with respect to induction of pro-inflammatory genes
and type I IFNs but Pellino3 deficiency leads to augmenta-
tion of TLR-3 induced expression of type I IFNs (Fig. 1).
The enhanced expression of IFNs confers on Pellino3-defi-
cient mice a greater ability to clear encephalomyocarditis
virus (EMCV). These findings indicate that Pellino3 nega-
tively regulates TLR3-induced expression of type I IFNs and
the underlying mechanism involves the targeting and inhibi-
tion of the transcription factor IRF7. In this model, TLR3
induces expression of Pellino3, via the TRIF/TBK1/IRF3 sig-
naling axis, followed by interaction of Pellino3 with TRAF6
(Fig. 1). Pellino3 promotes polyubiquitination of TRAF6 and
so precludes the interaction of TRAF6 with IRF7 and impairs
polyubiquitination of the latter. Since ubiquitination of IRF7
is associated with its activation (58), Pellino3 acts to inhibit
nuclear translocation of IRF7 to the IFNb promoter and so
decrease transcription of the Ifnb gene. This model thus
highlights an important physiological role for Pellino3 as
part of a negative feedback system in the TLR3 pathway in
which activation of TLR3 drives TRIF-induced expression of
Pellino3 that then targets IRF7 to repress ongoing TRIF-
induced transcription of IFNb. The negative regulation of
IFNb expression by Pellino3 is also employed by oxidized
low-density lipoprotein (oxLDL) to inhibit LPS-induced
expression of IFNb (59, 60). However, the mechanism
underlying these inhibitory effects of Pellino3 differ from its
regulatory effects in the TLR3 pathway in that OxLDL, via
the scavenger receptor-A1, activates Pellino3 to catalyze
monoubiquitination of the protein TANK that normally acts
as an adapter to connect TRAF3 to TBK1/IKKe and ulti-
mately activation of IRF3 (60). Monoubiquitination of
TANK precludes the association of TBK1 with TRAF3 and
manifests oxLDL-mediated inhibition of IFNb expression
(60).
The regulatory effects of Pellino3 on IFNb expression
highlights opposing functions for members of the Pellino
family in that the inhibitory roles of Pellino3 in TRIF signal-
ing (57) contrast with the positive mediatory roles of Pelli-
no1 in TRIF-dependent pathways (49, 55). However, given
the various roles of the family members in this pathway and
its importance in antiviral signaling we were intrigued to
discover a viral Pellino homologue in an entomopoxvirus
that, while lacking a RING-domain, contains a FHA domain
and interferes with TLR-induced activation of NF-jB (61).
The existence of a viral Pellino homologue implicates poten-
tial functional importance for Pellino proteins in antiviral
immunity. Viruses tend to develop evasive strategies by tar-
geting critical components of the antiviral response in the
host. However, to date no homologues of Pellino have been
found in viruses that show tropism for mammals.
Pellino2 and TLR4 signaling
Details on the role of Pellino2 in TLR signaling are relatively
sparse. Knockdown of Pellino2 inhibits LPS-induced poly-
ubiquitination of IRAK-1 (62) and activation of NF-jB (27,
63) and ERK and JNK pathways (62). It has also been
shown that LPS promotes the interaction of Pellino2 with
BCL10 to trigger downstream activation of NF-jB with
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suppressor of cytokine signaling 3 (SOCS3) being capable of
targeting this interaction to mediate IL-10-induced suppres-
sion of LPS signaling (63).
Pellino3 mediates Nod2 signaling
Much research focus in the Pellino field has explored the
physiological roles of these proteins in TLR signaling. How-
ever, we have delineated a novel function for Pellino3 as a
mediator in the pathway triggered by NOD2, a member of
the NLR pathway (64) (Fig. 2). NOD2 is as an important
player in regulating intestinal inflammation with loss of
function mutations in NOD2 being associated with increased
susceptibility to Crohn’s disease (65–68). Nod2 senses bacte-
rial infection by recognizing peptide derivatives of peptido-
glycan (69, 70) and responds by recruiting and stimulating
K63-linked ubiquitination of RIP2 kinase. In an analogous
way to TRAF6 and RIP1 described earlier, the ubiquitination
of RIP2 serves as a recruitment platform for TAK1 and IKK
complexes facilitating NF-jB and MAPK activation and the
induction of inflammatory genes (71–74). While a number
of E3 ubiquitin ligases such as TRAF6 (73), cellular inhibitor
of apoptosis proteins (cIAPs), and XIAP proteins (75–77)
and ITCH (78) are proposed to mediate ubiquitination of
RIP2, the functional importance of these effects remain to be
defined (74, 76, 78, 79) and the identity of the functionally
relevant E3 ligase for RIP2 is uncertain. We have recently
used cells from Pellino3-deficient to demonstrate that Pelli-
no3 is a key mediator of NOD2 signaling by acting as a
direct E3 ligase for RIP2, promoting its K63-linked ubiquiti-
nation and triggering downstream activation of NF-jB and
expression of pro-inflammatory proteins (64) (Fig. 2). We
also propose that the Pellino3-induced ubiquitination of
RIP2 may facilitate subsequent linear ubiquitination of the
RIP2 signaling complex by XIAP. This would allow TAK1 to
be recruited to the K63-linked chains and the NEMO compo-
nent of the IKK complex to associate with linear chains thus
facilitating TAK-1-induced activation of IKKs and down-
stream signaling (79, 80). This has intriguing similarity to a
report proposing that IL-1 and TLR-induced activation of
IKKs involves the modification of IRAK-1 and IRAK-4 by
hybrid ubiquitin chains in which the IRAKs are initially
modified by K63-linked chains to which linear chains are
subsequently added (81). A paradigm may be arising in
which Pellino proteins seed proteins for linear ubiquitination
by initial attachment of K63 chains.
Given the importance of functional NOD2 in ensuring
intestinal homeostasis, we also highlighted the physiological
importance of Pellino3 in facilitating this homeostatic role
of NOD2 by demonstrating more severe intestinal inflamma-
tion in Pellino3 knockout mice relative to wildtype counter-
parts when these mice were subject to various forms of
experimental colitis (64). It was important to explore if this
protective role of Pellino3 extended into a human context
and the greatly decreased levels of Pellino3 that we observed
in the colons of Crohn’s disease patients certainly adds fur-
ther credibility to Pellino3 deficiency being a significant
contributory factor to intestinal pathophysiology.
Pellino proteins as regulators of IL-1 and TNF signaling
Given that the first Pellino protein was discovered in Drosoph-
ila Toll signaling and this pathway is highly conserved in
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Fig. 2. Pellino3 ubiquitinates RIP2 and mediates NOD2 signaling.
The peptidoglycan-derived muramyl dipeptide (MDP) from bacterial
pathogens triggers oligomerization of NOD2 that then utilizes its
CARD domain to recruit the CARD-containing RIP2 kinase. Pellino3 is
subsequently recruited to RIP2 and catalyses K63-kinked
polyubiquitination of RIP2 allowing for co-recruitment of the TAK1
and IKK complexes. This facilitates TAK1-mediated activation of IKKs
and downstream activation of NF-jB and activation of MAPK pathways
that results in activation of AP-1. NF-jB co-operates with AP-1 to
induce expression of cytokines, chemokines, and bactericidal peptides.
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composition and organization, it not surprising that most
research to date has focused on the potential roles of Pellino
proteins in the related TLR pathways. However, we and oth-
ers have also explored Pellino biology in the context of sig-
naling pathways employed by some of the effector pro-
inflammatory cytokines that are induced by TLRs. The IL-1
signal transduction pathway is especially pertinent given that
IL-1R shares its TIR domain with TLRs and uses IRAK kinas-
es to mediate MyD88-dependent signal transduction. TNF
signaling was also of interest to our laboratory, since while
not employing IRAK kinases, the TNF pathways are critically
dependent on RIP kinases and it is clear from above that
there is an emerging strong theme of an intimate relation-
ship between the Pellino and RIP kinase families of proteins.
Are Pellino proteins involved in IL-1 signaling?
Early studies implicated a signaling role for Pellino1 in the
IL-1 pathway by virtue of knockdown of Pellino1 suppress-
ing IL-1-induced activation of NF-jB and induction of pro-
inflammatory gene expression in HEK293 cells (28) and a
murine intestinal epithelial cell line (82). Interestingly the
latter study also reported that the anti-inflammatory cytokine
TGF-b inhibits IL-1 signaling by inducing the inhibitory
Smad6 protein to interact with Pellino1 and disrupt Pellino1
association with IRAK-1, IRAK-4, and TRAF-6. A more
recent study has suggested that TGF-b also induces the
related Smad7 protein to target Pellino1 and block the inter-
action of the latter with the IRAK-1/IRAK-4/TRAF-6 com-
plex resulting in reduced IL-1 and LPS signaling (83). Both
Smad6 and Samd7 are proposed to work in tandem, via
their MH2 domains, to simultaneously target different
regions of Pellino1 (residues 1–137 for Smad6 and residues
198–345 for Smad7) and optimally disrupt Pellino1 binding
to its signaling complex. These findings suggest that Pelli-
no1, via its interaction with the IRAK signaling complex,
plays an important mediatory role in IL-1 signaling. How-
ever, IL-1 signaling is not affected in cells from IRAK-1
kinase-dead knockin mice that lack Pellino1 E3 ligase activity
(44). Furthermore, Pellino1 does not regulate IL-1-induced
polyubiquitination of IRAK-1 in HEK293 cells (62), and IL-
1 signaling is fully intact in murine embryonic fibroblasts
(MEFs) from Pellino1-knockout mice (49), suggesting that
Pellino1 does not play a role in the IL-1 pathway.
Early studies in the field also demonstrated that knock-
down of Pellino2 inhibits IL-1 induced activation of NF-jB
(27, 63). Overexpression of Pellino2 in cells triggers activa-
tion of the ERK and JNK MAPK pathways (33) with Pellino2
knockdown attenuating IL-1 and LPS-induced activation of
the MAPK pathways and decreasing the stability of tran-
scripts encoding IL-6, IL-8, and TNF (62). Pellino2 knock-
down also inhibits IL-1-induced polyubiquitination of IRAK-
1 suggesting that Pellino2 may play a key role in promoting
IRAK-1 ubiquitination and triggering downstream activation
of the ERK and JNK pathways. The physiological role of Pel-
lino2 in immunity awaits the generation of genetic models.
Overexpression of Pellino3 can activate ERK (29), JNK
(29, 84), and p38 MAPK (38), while Pellino3 knockdown
inhibits IL-1 and LPS-induced activation of p38 MAPK, the
transcription factor cAMP-responsive-element-binding pro-
tein (CREB) and expression of the CREB-responsive gene IL-
10 (38, 85). Similar approaches have suggested the shorter
spliced form Pellino3b, negatively regulates IL-1-induced
TAK-1-dependent NF-jB activation by ubiquitinating and
stabilizing IRAK-1 with K63-linked chains, thus sequestering
the TAK-1- complex in the membrane and preventing its
activation of NF-jB in the cytosol (84). However, in the last
few years we have generated Pellino3-deficient mice and
have yet to detect any deficiency in IL-1 signaling.
It is clear from above that the role of Pellino proteins in
IL-1 signaling is far from certain. This is somewhat surpris-
ing given that Pellino proteins were discovered as IRAK-
interacting proteins, and IRAK kinases play important role in
the IL-1 pathway. This suggests that Pellino proteins may
have more functionally relevant substrate proteins such as
TRAF6 and RIP kinases as described above. The critical role
of the latter in TNF signaling prompted enthusiasm in our
laboratory to probe the potential involvement of Pellino
proteins in TNF pathways.
Pellino3 controls cell fate in TNF signaling
Early studies in the Pellino field had indicated a lack of role
for Pellino1 and Pellino2 in TNF-induced activation of NFjB
(27, 28), but we have recently demonstrated an important
role for Pellino3 in controlling cell fate in response to TNF
(86) (Fig. 3). TNF can activate NF-jB and induce pro-
inflammatory gene expression but can also be a critical
determining factor in dictating whether a cell lives or dies
(79, 87). Stimulation of TNF receptor I (TNF-R1) leads to
association of the latter with TNF-R1-associated death
domain protein (TRADD) (88) and RIP1 (89) followed by
recruitment of a number of E3 ubiquitin ligases including
TRAF2, TRAF5, cIAP1, and cIAP2 thus forming a large mul-
timeric complex termed Complex I (90–93) (Fig. 3). These
E3 ligases catalyze polyubiquitination of RIP1 that is then
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recognized by the ubiquitin-binding domains of proteins in
the IKK and TAK1 complexes resulting in activation of NF-
jB and pro-inflammatory gene expression (79, 94). While
NF-jB can also induce anti-apoptotic genes to protect cells
from death (95–97), de-ubiquitination of RIP1 represses
activation of NF-jB, and the unmodified RIP1 associates
with Fas-associated death domain (FADD) protein and
pro-caspase8 to form Complex II [also known as death
inducing signaling complex (DISC)] (98–100). Complex II
promotes processing and activation of caspase8 triggering
the caspase cascade and apoptosis (101). Caspase8 can also
cleave RIP1 to further augment TNF-induced apoptosis.
Interestingly, we have shown that loss or knockdown of Pel-
lino3 expression sensitizes cells to TNF-induced apoptosis
without regulating activation of the NF-jB pathway (102).
Instead Pellino3 is cytoprotective by interacting, via its FHA
domain, with RIP1 and blocking the interaction of the latter
with FADD and caspase8 (Fig. 3). This prevents downstream
caspase activation and apoptosis and also reduces caspase8-
mediated cleavage of RIP1 to favor cell survival as an out-
come to TNF signaling. Furthermore, TNF-induced hepato-
toxicity and lethality is exacerbated in Pellino3-deficient
mice (86), emphasizing the physiological importance of Pel-
lino3 in regulating cell survival in response to TNF chal-
lenge. While the targeting of RIP1 is central to this
regulation by Pellino3, intriguingly the effects are indepen-
dent of its RING-like domain and, unlike the effects of Pelli-
no1, are not mediated by affecting the ubiquitination status
of RIP1. This indicates that Pellino proteins may also have
functional roles that are independent of E3 ligase activity.
This study in conjunction with the other emerging roles of
the Pellino family serves to further highlight an expanding
theme of Pellino proteins targeting kinase families, such as
the IRAKs and RIPs, to regulate immune signaling.
Pellino proteins as regulators and mediators of disease
Given the emerging roles of Pellino proteins in innate
immune signaling, coupled to the propensity of dysregulat-
ed immune responses to trigger disease, it is not surprising
that various reports implicate Pellino proteins as regulators
of pathophysiology. As already stated, we have demonstrated
Pellino3 expression to be greatly diminished in colon sam-
ples from patients with Crohn’s disease and given that we
have also shown Pellino3-deficient mice to have aggravated
pathology in colitis models, we propose a protective role
for Pellino3 in inflammatory bowel disease (64). Elevated
levels of Pellino1 and Pellino2 have been recorded in asth-
matics (103), children with protracted bacterial bronchitis
(104), and in transplant patients with acute kidney rejection
(105). Furthermore, polymorphisms in the PELI1 locus, that
encodes Pellino1, associate with vasculitis in young children
(106, 107) and with increased susceptibility to systemic
lupus erythematosus in a Chinese population (108). While
the latter studies are restricted to interpreting association of
Pellino genes and proteins with disease, a number of disease
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Fig. 3. Pellino3 protects cells from pro-apoptotic effects of TNF.
Stimulation of TNF-RI with TNF leads to association with the adapter
protein TRADD and RIP1 kinase. This is followed by recruitment of the
E3 ubiquitin ligases TRAF2, TRAF5, cIAP1, and cIAP2 that catalyze
K63-linked polyubiquitination of RIP1 as part of a multimeric complex
termed Complex I. Ubiquitinated RIP1 deploys TAK1 and IKK
complexes to activate NF-jB and induce pro-inflammatory gene
expression. NF-jB also induces anti-apoptotic proteins that favor cell
survival. Deubiquitination of RIP1 leads to its re-distribution to
Complex II [also known as Death induced signaling complex (DISC)]
with the death effector domain (DED)-containing Fas-associated death
domain protein (FADD) and procaspase8. This results in auto-
processing of caspase8 to generate catalytically activate caspase8 that
triggers a downstream caspase cascade and ultimately apoptosis and
cell death. Active Caspase8 can also cleave RIP1 to impair its cell
survival roles. Pellino3 blocks the killing effects of TNF by interacting
with RIP1 in a TNF-dependent manner to preclude the association of
RIP1 with FADD and caspase8 thus reducing complex II formation and
impairing the pro-apoptotic pathway. This also prevents caspase8-
mediated cleavage of RIP1 to retain the pro-survival roles of the latter.
TNF, tumor necrosis factor; NF-jB, nuclear factor-jB.
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models have recently highlighted that Pellino proteins may
play key roles in various pathogenic processes. These range
from Pellino1 being shown to regulate autoimmunity and
lymphomagenesis to a very recent study from our own
group showing that Pellino3 plays a protective role in obes-
ity-driven insulin resistance.
Pellino1 and autoimmunity
While Pellino1-deficient mice were initially observed to
develop and grow normally, it was noticed that, with aging,
these mice had enlarged lymph nodes and inflammatory cell
infiltrates in tissues, strongly suggesting that absence of Pelli-
no1 is associated with spontaneous autoimmunity (109).
These mice also display higher frequency and number of
memory T cells but lower frequency of naive cells. Costimula-
tion of the T-cell receptor (TCR) and CD28 in their CD4+ and
CD8+ T cells result in hyper-activation and enhanced prolifer-
ation compared to the same cells from wildtype mice. TCR/
CD28 normally activates NF-jB subunits like c-Rel to induce
CD28-responsive gene such as IL-2 that drives autocrine T-cell
activation and proliferation whereas TCR activation in the
absence of CD28 results in T-cell anergy. Interestingly, Pelli-
no1 is induced in response to TCR/CD28 costimulation and
promotes K48-linked polyubiquitination of c-Rel followed by
c-Rel degradation (109). In the absence of Pellino1, TCR/
CD28 promotes sustained activation of c-Rel that drives dys-
regulated activation and proliferation of T cells ultimately
compromising self-tolerance (109, 110). Given this proposed
role for Pellino1 in preventing autoimmunity it was some-
what surprising that a subsequent study described less severe
experimental autoimmune encephalomyelitis (EAE), a murine
model of multiple sclerosis, in Pellino1-deficient mice (111).
However, the latter study described a microglia-specific role
for Pellino1 in driving neuroinflammation. Pellino1 is unique
in its family with its high level of expression in microglia.
While the initial studies in macrophages and dendritic cells
from Pellino1-deficient mice indicated Pellino1 to play a
selective role in TRIF-mediated signaling (49), Pellino1 medi-
ates MyD88 signaling in microglia, with loss of Pellino1
resulting in impaired pro-inflammatory gene induction by
TLRs that use MyD88 as their exclusive adapter molecule
(111). Intriguingly, Pellino1 does not regulate MyD88-
induced activation of NFjB in microglia but instead mediates
MyD88 signaling that leads to ERK, JNK, and p38 MAPK path-
ways. In microglia, MyD88 employs Pellino1 to mediate
TRAF6-induced activation of cIAP1 and cIAP2 (112). The
activated cIAP E3 ligases facilitate ubiquitination and
degradation of TRAF3 (that normally tethers the MyD88
signaling complex to the membrane), thus allowing the liber-
ated complex to sequentially activate TAK-1 and MAPKs in
the cytosol and induce pro-inflammatory gene expression. In
this pathway, Pellino1 seems to target cIAP2 since Pellino1-
deficient microglia show impaired TRAF6-induced ubiquiti-
nation of cIAP2. However, it is not known if Pellino1 is the
direct upstream E3 ligase for cIAP2. It should be noted that
this defective MyD88 signaling, in the absence of Pellino1,
applies specifically to microglia and not to peripheral immune
cells. The latter express high levels of all Pellino family mem-
bers (109), and thus the loss of Pellino1 may be masked by
functional compensation by Pellino2 and/or Pellino3. These
experimental models thus implicate Pellino1 as a mediator of
neuroinflammation. This may have pathophysiological rele-
vance since Pellino1 expression is increased in EAE and more
pertinently in post mortem brain samples from patients with
multiple sclerosis (111). Given neuroinflammation underlies
a number of neurodegenerative disorders, it will be interest-
ing to further explore the potential contribution of the Pellino
proteins to various neuropathological states.
Pellino1 contributes to cardiac dysfunction
Recent reports have demonstrated Pellino1 to make an
important contribution to cardiac dysfunction following
myocardial infarction or mechanical stress (113, 114). Pelli-
no1 expression was shown to be increased in cardiomyo-
cytes and fibroblasts under hypoxic conditions in a murine
model of myocardial infarction (113). Conditional deletion
of Pellino1 in the myocardium or cardiac delivery of Pelli-
no1 siRNA suppresses myocardial infarction-induced cardiac
dysfunction, reduces scar size, and decreases pro-inflamma-
tory gene expression and cardiac infiltration of inflammatory
leukocytes. The protective effects of Pellino1 suppression are
also paralleled with decreased ubiquitination of RIP1, and so
the contribution of Pellino1 to cardiac damage may be due
to its ability to promote ubiquitination of RIP1 and down-
stream pro-inflammatory signaling in TLR3 and TLR4 path-
ways (as described earlier). Similarly suppression of Pellino1
expression reduces mechanical stress-induced cardiac dys-
function, cardiac hypertrophy and cardiac fibrosis in rat
hearts and these protective effects are associated with
reduced expression of TGFb (114).
Pellino1 promotes lymphomagenesis
The generation of Pellino1 transgenic mice, in which
expression of the Pellino1 transgene is under the control of
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the B-actin and CMV promoters, has revealed a potential role
for Pellino1 in driving B-cell lymphoma formation (50).
These mice display premature mortality with over half of the
mice showing a wide range of tumors in various tissues. A
particularly high frequency of lymphoid tumors in the thy-
mus, spleen and lymph nodes are observed and these lym-
phoid tissues are characterized by increased numbers of
proliferating and activated B cells. Interestingly tumors in the
non-lymphoid tissue from the Pellino1 transgenic mice also
demonstrate high numbers of proliferating B cells suggesting
that overexpression of Pellino1 drives tumor formation that is
strongly associated with B-cell activation and infiltration.
Indeed the enhanced expression of Pellino1 was shown to
drive lymphomagenesis. A mechanistic explanation was pro-
vided for these effects of Pellino1 by demonstrating that Pelli-
no1 can interact with and promote K63-linked
polyubiquitination and stabilization of the proto-oncogene
BCL6. Furthermore, there is a strong correlation between the
levels of Pellino1 and BCL6 in various B-cell lymphoma cell
lines and this correlation extends to cells from patients with
diffuse large B-cell lymphomas. This latter correlation may be
of particular pathological relevance given that BCL6 can facili-
tate lymphomagenesis in diffuse large B-cell lymphomas
(115) and high Pellino1 expression is associated with poor
prognosis and survival outcome for patients with these lym-
phomas (50). The Pellino1-driven K63-linked ubiquitination
of BCL6 presumably opposes the degradative K48-linked
polyubiquitination that is normally catalyzed by the SKP1-
CUL1-F-box protein (SCF) ubiquitin ligase complex and the
stabilizing effect of Pellino1 on BCL6 may be especially mani-
fested in diffuse large B-cell lymphomas given that the F-box
protein FBXO11 of the SCF complex is inactivated in these
lymphomas (116). Such findings highlight the potential for
Pellino1 to be targeted therapeutically in relevant lymphomas.
However, it should be noted that the above pro-tumorigenic
role for Pellino1 was demonstrated in Pellino1 transgenic
mice in which the Pellino1 transgene is randomly integrated
into the genome and under the control of strong promoters.
To further evaluate the suitability of Pellino1 as a therapeutic
target in cancer, it would be valuable to assess the outcome of
preclinical studies that characterize tumorigenesis in Pellino1-
deficient mice.
Pellino3 protects against obesity-induced insulin
resistance
It is well-accepted that obesity can drive low level inflam-
mation resulting in damaging effects on metabolic health as
clinically manifested by insulin resistance and diabetes
(117). We observed reduced Pellino3 expression in human
abdominal adipose tissue in obese subjects and in adipose
tissue of mice fed on a high fat diet and this prompted us
to probe the potential role of Pellino3 in regulating obesity-
driven inflammation and insulin resistance (118). Intrigu-
ingly Pellino3-deficient mice demonstrate exacerbation of
high fat diet-induced glucose tolerance, insulin resistance
and hyperinsulinemia. We probed the mechanism underly-
ing the enhanced insulin resistance and revealed that Pelli-
no3 deficiency results in more inflamed adipose tissue as
manifested by accumulation of adipose tissue macrophages,
especially of the pro-inflammatory M1 subtype. Indeed we
revealed an intrinsic role for Pellino3 in negatively regulat-
ing macrophage M1 polarization. This results in enhanced
levels of pro-inflammatory proteins in the adipose tissue
and serum of Pellino3-deficient mice on a high fat diet and
these mice also display aggravated hepatic steatosis, a signa-
ture of obesity-driven inflammation. These findings clearly
indicate that Pellino3 plays a role in controlling the extent
of obesity-driven inflammation and in protecting against
insulin resistance. We also delineate the mechanisms under-
lying these regulatory effects of Pellino3 on obesity-driven
inflammation by showing that Pellino3 inhibits the tran-
scription of the gene encoding IL-1b. This is of particular
pathophysiological relevance since IL-1b is a critical media-
tor of insulin resistance and diabetes (119) and has become
an important focus for therapeutic intervention in these con-
ditions (120). The transcription of the Il1b gene is driven by
the transcription factors NF-jB and hypoxia inducible fac-
tor-1a (HIF-1a) (121, 122) and we show that Pellino3
inhibits Il1b gene transcription by negatively regulating the
stability of HIF-1a (118). Under normoxic conditions HIF-
1a is modified by proline hydroxylation resulting in its
K48-linked polyubiquitination and proteasomal degradation
(123, 124) whereas in hypoxia, the low levels of oxygen
precludes hydroxylation of HIF-1a resulting in its stabiliza-
tion. We describe an additional mechanism that can further
stabilize HIF-1a in that stimuli such as hypoxia, LPS and
fatty acids, conditions that are commonly found in obese
adipose tissue (125, 126), can trigger TRAF6 to catalyse
K63-linked ubiquitination of HIF-1a and so preclude K48-
linked ubiquitination resulting in enhanced stability (118)
(Fig. 4). We also demonstrate that Pellino3 mediates ubiq-
uitination of TRAF6 and so blocks the interaction of TRAF6
with HIF-1a, resulting in reduced K63-linked ubiquitination
and destabilization of HIF-1a. Thus, the protective effects of
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Pellino3 in tempering obesity-driven inflammation and insu-
lin resistance is underpinned by Pellino3 targeting TRAF6,
leading to destabilization of HIF-1a and reduced expression
of IL-1b.
A recent report has proposed that Pellino3 mediates the
expression of pro-IL-1b, the precursor of IL-1b, and TNF
in response to LPS (45). The authors demonstrate that
Pellino3-specific shRNA cause partial inhibition of LPS-
induced expression of IL-1b and TNF in macrophages.
The proposed role of Pellino3 in mediating TNF and IL-
1b expression in response to stimulation of macrophages
with LPS differs from our conclusions from studies in
macrophages from Pellino3-deficient mice (57, 118). We
show no deficiency in LPS-induced expression levels of
TNF in Pellino3-deficient macrophages (57) and aug-
mented induction of IL-1b in response to co-stimulation
of these macrophages with LPS and the fatty acid palmi-
tate. (118). Whilst the basis to such differences are not
immediately apparent, our studies to date on the physio-
logical role of Pellino3 emphasize its anti-inflammatory
function in preventing exaggerated inflammatory responses
as highlighted by its protective roles in inflammatory
bowel diseases and obesity-driven inflammation and insu-
lin resistance.
Closing perspective
The highly conserved nature of innate immune signaling
across evolution has proved highly valuable in using our
understanding of the composition and organization of sig-
naling pathways in primitive organisms to inform and aid
discovery of equivalent systems and molecules in more
advanced mammalian species. Such a relationship has proved
very valuable in our journey to date through the field of
Pellino biology. The first identification of a Pellino protein
in Drosophila and its implied function in innate immunity
provided a valuable reference to identify the three members
of the mammalian Pellino family and informed the frame-
work to explore their physiological roles. Whilst still early
in this field of discovery and perhaps not receiving as much
attention and profile as other related signaling molecules
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Fig. 4. Pellino3 protects against obesity-induced inflammation and insulin resistance. M1 macrophages in obese adipose tissue are subject to
various stimuli including lipopolysaccharide (LPS), palmitate, and hypoxia. These stimuli can trigger TRAF6 to activate NF-jB and to catalyze
K63-linked ubiquitination and stabilization of HIF-1a. NF-jB and HIF-1a co-operate to induce transcription of the gene encoding IL-1b that
drives inflammation-induced insulin resistance. Pellino3 acts to catalyze polyubiquitination of TRAF6 that inhibits the TRAF6/HIF-1a interaction,
resulting in destabilization of HIF-1a. This impairs nuclear translocation of HIF-1a, repression of IL-1b expression and protection from
inflammation-induced insulin resistance. IL-1, interleukin-1; NF-jB, nuclear factor-jB; HIF-1a, hypoxia inducible factor-1a.
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that have been studied for longer, it is clear that Pellino pro-
teins are emerging to be key players in immune signaling
and an increased understanding of their biology can only
aid our global appreciation of the workings of innate and
adaptive immunity. It is also obvious that Pellino members
have evolved far beyond their primary characterized role of
targeting the IRAK homologue, Pelle. Whilst this interaction
has been conserved in nature by virtue of IRAK-Pellino
interactions, studies to date clearly emphasize that Pellino
proteins have multiple targets beyond IRAKs. Indeed it is
somewhat ironic that whilst the field has accrued detailed
information on the nature of the molecular interactions
between the IRAK and Pellino proteins, we have better
understanding of the physiological or pathophysiological
relevance of some of the other interactions of Pellino mem-
bers with target proteins such as RIP kinases and TRAF6.
Our increased awareness and identification of an increasing
number of Pellino interactors is also helping to inform us
about the diverse functions of these family members. In
addition a single family member may target the same mole-
cule to manifest various biological outcomes. This is indi-
cated by our own studies that have revealed Pellino3 to
ubiquitinate TRAF6 and so block TRAF6 interaction with
IRF7 and repress type I IFN expression whilst Pellino3 can
similarly target TRAF6 to preclude its binding to and activa-
tion of HIF-1a resulting in reduced expression of IL-1b and
protection from the development of insulin resistance.
The ever expanding delineation of new roles for Pellino
proteins is also highlighting that different members of the
Pellino family fail to show functional redundancy and
instead appear to have specialized roles. This appears sur-
prising given the homology of the members and their com-
mon RING-like and FHA domains. Some of the specificity
may be due to cell restricted expression of individual mem-
bers such as predominant expression of Pellino1 in micro-
glia and its role in mediating neuroinflammation. The
Pellino proteins may also be subjected to differential regula-
tion by varying kinases and indeed as discussed earlier
different kinases phosphorylate and activate the Pellino pro-
teins in the context of varying signaling pathways. Finally
the most important determinant in dictating functional spec-
ificity for individual Pellino proteins may be facilitated by
selective substrate recognition. The latter may seem unlikely
given that the Pellino proteins share a FHA domain that can
serve to recognize phosphorylated residues on target pro-
teins to be ubiquitinated. However, the FHA domains from
the Pellino members display varying affinities for different
sequences that surround the phospho-threonine residues in
target proteins (42) and this may facilitate that specificity of
function for individual Pellino proteins.
While much of our detailed knowledge on Pellino biol-
ogy focuses on the physiological roles of the family mem-
bers, it is also clearly emerging that these proteins can
contribute to and regulate diseases processes. Given this
insight efforts will inevitably turn to designing strategies to
target Pellino proteins for therapeutic application. A very
recent study has provided the first indication that the spe-
cific targeting of Pellino proteins may be a fruitful avenue
for new drug discovery. As described previously, TGF-b
inhibits IL-1 and LPS signaling by inducing the inhibitory
Smad6 and Smad7 proteins that subsequently interact with
Pellino1 and disrupts Pellino1 signaling complexes (82, 83).
Interestingly a synthetic membrane-tethered peptide corre-
sponding to residues 422–441 of Smad6 has been recently
shown to interact with Pellino1 and disrupt the TLR4-
induced signaling complexes containing Pellino1 with RIP1
and IKKe/TBK1 (127). This peptide shows therapeutic
potential in the treatment of experimental models of LPS- or
polymicrobial-induced sepsis. This provides the first indica-
tion that Pellino proteins may be open for future exploita-
tion as therapeutic targets. Such exciting promise heightens
the need for continuing and expanding research on the
molecular, physiological and pathophysiological roles of the
Pellino family.
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